作者: 水土 時間: 2025-3-21 21:53 作者: enormous 時間: 2025-3-22 01:36
Hack the world a better place!,eceptor activating it and resulting in the clinical manifestations of hyperthyroidism. One of the most serious complications of GD is Graves’ ophthalmopathy (GO), a complex chronic autoimmune inflammation affecting the orbital and retro-orbital tissues. Epidemiological studies and sibling and twin s作者: 儲備 時間: 2025-3-22 06:44 作者: 越自我 時間: 2025-3-22 10:17 作者: 寬宏大量 時間: 2025-3-22 14:46 作者: 寬宏大量 時間: 2025-3-22 17:07
https://doi.org/10.34156/9783791053769 among older children when administered in a dose that destroys most thyroid tissue and results in hypothyroidism. It is contraindicated in pregnancy and lactation and when patients are unable to comply with radiation safety precautions. It is relatively contraindicated in patients with active ophth作者: needle 時間: 2025-3-23 00:48 作者: 脆弱帶來 時間: 2025-3-23 04:24 作者: Noisome 時間: 2025-3-23 05:53 作者: 攤位 時間: 2025-3-23 16:46 作者: Wernickes-area 時間: 2025-3-23 21:06 作者: cylinder 時間: 2025-3-24 01:57 作者: garrulous 時間: 2025-3-24 02:31 作者: eucalyptus 時間: 2025-3-24 06:54
https://doi.org/10.1007/978-3-531-92471-7 pathogenetic mechanisms of the disease. Graves’ orbitopathy (GO), the most frequent extrathyroidal manifestation of Graves’ disease, is present in about 25 % of newly diagnosed Graves’ patients, and rarely progresses over time. Neither ATDs nor thyroidectomy appear to affect the natural course of G作者: 雪崩 時間: 2025-3-24 14:26 作者: Resistance 時間: 2025-3-24 18:06 作者: 值得尊敬 時間: 2025-3-24 19:13
Christian Hey,Ruggero Schleicher-Tappesersease process and allowing rehabilitative surgery, if still necessary, in an earlier stage. Till present, intravenously administered methylprednisolone has proved to be the most effective immunosuppressive treatment for patients with GO with few and minor complications as long as certain cumulative 作者: arrogant 時間: 2025-3-25 00:38
Professionalism and the Art of Patient-Centric Thyroidology,d not have foreseen the rapid march of medical science that occurred in the latter half of the twentieth century. They understood however that if patients were to fully benefit from advancing knowledge, both the art and science must together be applied. The discipline of endocrinology has been in th作者: 增強 時間: 2025-3-25 05:04 作者: 動機 時間: 2025-3-25 08:56
,Epidemiology and Genetic Factors in Graves’ Disease and Graves’ Ophthalmopathy,eceptor activating it and resulting in the clinical manifestations of hyperthyroidism. One of the most serious complications of GD is Graves’ ophthalmopathy (GO), a complex chronic autoimmune inflammation affecting the orbital and retro-orbital tissues. Epidemiological studies and sibling and twin s作者: Keratectomy 時間: 2025-3-25 13:01
Laboratory and Clinical Assessment of Hyperthyroidism,ion. This excess in thyroid hormone levels is often accompanied by suppressed serum TSH concentrations and a wide variety of clinical manifestations that often involve many organ systems. Graves’ disease, an autoimmune condition, is the most common cause of hyperthyroidism in the United States (80 %作者: 變白 時間: 2025-3-25 19:45
,Evidence-Based Discussion of Treatment Options for Graves’ Disease,ble evidence for a particular outcome is not informed solely by any single study, but rather by the accumulated evidence of all pertinent studies; and (3) when making decisions, the evidence about the relative benefits and harms of the available options is necessary but not sufficient to make a clin作者: 甜得發(fā)膩 時間: 2025-3-25 23:46
,Antithyroid Drug Therapy in Patients with Graves’ Disease, around the world, especially in Europe, South America, and Asia, but more commonly now also in the USA. The review discusses indications and contraindications for therapy as well as mechanisms of action of ATD. Practical guidance is given on initiation of ATD therapy, adjustment of drug dose, and o作者: 酷熱 時間: 2025-3-26 00:17 作者: ABYSS 時間: 2025-3-26 06:35
,Thyroidectomy in Patients with Graves’ Disease,c adenoma and toxic multinodular goiter. There is consensus now that total thyroidectomy is the preferred surgical approach to Graves’ disease, as subtotal and partial thyroidectomy are associated with high rates of recurrence and the need for higher-risk remedial surgery or additional treatment. Wh作者: 披肩 時間: 2025-3-26 10:00 作者: 取回 時間: 2025-3-26 13:43 作者: 諂媚于人 時間: 2025-3-26 19:35 作者: 名次后綴 時間: 2025-3-27 00:43 作者: Foolproof 時間: 2025-3-27 02:39 作者: 過渡時期 時間: 2025-3-27 07:07 作者: 暫時過來 時間: 2025-3-27 10:41 作者: 免費 時間: 2025-3-27 15:55
,Treatment of Hyperthyroidism in Patients with Graves’ Orbitopathy, pathogenetic mechanisms of the disease. Graves’ orbitopathy (GO), the most frequent extrathyroidal manifestation of Graves’ disease, is present in about 25 % of newly diagnosed Graves’ patients, and rarely progresses over time. Neither ATDs nor thyroidectomy appear to affect the natural course of G作者: 流動性 時間: 2025-3-27 19:23
,Assessment and Management Plan for Graves’ Orbitopathy, gradual onset of proptosis and lid retraction, usually associated with fat expansion on orbital imaging. In approximately one-third of cases, the disease develops rapidly with significant involvement of one or more extraocular muscles and resultant periocular soft tissue congestion, motility disrup作者: emulsify 時間: 2025-3-27 22:45 作者: 過渡時期 時間: 2025-3-28 02:59 作者: Hyperalgesia 時間: 2025-3-28 07:50 作者: MAPLE 時間: 2025-3-28 14:10
,Epidemiology and Genetic Factors in Graves’ Disease and Graves’ Ophthalmopathy, disease development. Our group and others have further focused on thyroid-specific genes such as TSH receptor and thyroglobulin gene and have shown that they play a major role in GD. Genetic studies in GO, however, did not show consistent results. Since the entire risk for GD is not conveyed by gen作者: Fabric 時間: 2025-3-28 15:09
,Evidence-Based Discussion of Treatment Options for Graves’ Disease,g the patients and clinicians make informed decisions consistent with the body of best available evidence and the appropriate application of the last principle by the implementation of shared decision making and decision aids.作者: Chameleon 時間: 2025-3-28 21:05 作者: acrophobia 時間: 2025-3-29 00:13 作者: 放棄 時間: 2025-3-29 06:13 作者: 捕鯨魚叉 時間: 2025-3-29 07:40
,Graves’ Disease and Pregnancy,is secondary to the thyrotrophic effect of human chorionic gonadotropin, is self-limiting, and does not require treatment. Management of Graves’ thyrotoxicosis is predominately via antithyroid drugs. Propylthiouracil is recommended in the first trimester and methimazole is preferred during the secon作者: Overstate 時間: 2025-3-29 11:30 作者: Antarctic 時間: 2025-3-29 18:57
Thyroid Dermopathy and Acropachy,es not responding to local corticosteroid therapy. In future any systemic therapy proven to be beneficial for ophthalmopathy can be used empirically for refractory cases of dermopathy..For thyroid acropachy no specific therapy has been reported and management should be preventive and local therapy f作者: 法律的瑕疵 時間: 2025-3-29 20:15 作者: antidote 時間: 2025-3-30 01:32
Natural History, Risk Factors, and Management of Patients with Mild GO,D. TSH receptor antibody titer (TRAb) can be employed to predict the subsequent course of GO in about 50 % of patients. Despite this knowledge the identification of GO cases without associated clinical thyroid abnormalities, the cases of unilateral GO, the presence of GO in nonsmokers and cases of e作者: 披肩 時間: 2025-3-30 06:48
Julia Plugmann,Philipp Plugmannations, that stimulate the TSHR. Assays for these antibodies are unconventional and involve either inhibition of TSH binding to its receptor or generation of cAMP from monolayers of TSHR-expressing cells. The epitopes recognized by TSHR antibodies are not linear but conformational. In rare patients,作者: Itinerant 時間: 2025-3-30 10:40 作者: 勤勞 時間: 2025-3-30 13:25
Nachhaltigkeit im Beschaffungsmanagementg the patients and clinicians make informed decisions consistent with the body of best available evidence and the appropriate application of the last principle by the implementation of shared decision making and decision aids.作者: Archipelago 時間: 2025-3-30 16:50 作者: 輕彈 時間: 2025-3-30 21:56 作者: cornucopia 時間: 2025-3-31 02:57
,Organisationstheoretische überlegungen,idectomy in children are considerably higher than in adults; thus an experienced thyroid surgeon is needed when children are operated on. Most importantly, the care of children with GD can be complicated and requires physicians with expertise in the area.作者: 刺穿 時間: 2025-3-31 07:59
https://doi.org/10.1007/978-3-8349-8861-4is secondary to the thyrotrophic effect of human chorionic gonadotropin, is self-limiting, and does not require treatment. Management of Graves’ thyrotoxicosis is predominately via antithyroid drugs. Propylthiouracil is recommended in the first trimester and methimazole is preferred during the secon作者: Melanoma 時間: 2025-3-31 09:14
Nachhaltigkeit in der Unternehmenspraxisted that physical and/or functional relationships may exist between TSHR and IGF-1R in GO. A current concept integrating these findings is that activation of both receptors within the orbit, perhaps by TRAb as well as locally produced IGF-1, may be involved in the development of the ocular manifesta作者: fatty-acids 時間: 2025-3-31 17:02
Grundlagen der empirischen Untersuchung,es not responding to local corticosteroid therapy. In future any systemic therapy proven to be beneficial for ophthalmopathy can be used empirically for refractory cases of dermopathy..For thyroid acropachy no specific therapy has been reported and management should be preventive and local therapy f作者: FECT 時間: 2025-3-31 21:24 作者: Pantry 時間: 2025-4-1 00:00
https://doi.org/10.1007/978-3-662-66047-8D. TSH receptor antibody titer (TRAb) can be employed to predict the subsequent course of GO in about 50 % of patients. Despite this knowledge the identification of GO cases without associated clinical thyroid abnormalities, the cases of unilateral GO, the presence of GO in nonsmokers and cases of e作者: anesthesia 時間: 2025-4-1 03:04
Nachhaltigkeit im Eventmanagementn the withdrawal of therapy. Side effects to the drugs are reviewed in detail and principles of ATD pretreatment before and after radioiodine as well the possibility of continuous low-dose ATD therapy are discussed.作者: 全面 時間: 2025-4-1 08:56 作者: 沖擊力 時間: 2025-4-1 12:39 作者: ear-canal 時間: 2025-4-1 16:54
,Antithyroid Drug Therapy in Patients with Graves’ Disease,n the withdrawal of therapy. Side effects to the drugs are reviewed in detail and principles of ATD pretreatment before and after radioiodine as well the possibility of continuous low-dose ATD therapy are discussed.作者: arabesque 時間: 2025-4-1 21:27 作者: DNR215 時間: 2025-4-2 00:58
Impact of Hyperthyroidism on the Cardiovascular and Musculoskeletal Systems and Management of Patie and dilated cardiomyopathy represent important risk factors, which may play an important role in determining the poor cardiovascular outcome reported in autoimmune hyperthyroidism. The correction of overt and subclinical hyperthyroidism should be the first step in improving the prognosis of hyperthyroid patients with cardiovascular complications.作者: 攝取 時間: 2025-4-2 04:23
